Search

Search Results

1. Somatostatin receptor imaging of thyroid tissue and differentiated thyroid cancer using gallium-68-labeled radiotracers—a review of clinical studies

   Introduction

   The rise in thyroid cancer incidence, especially papillary thyroid cancer (PTC), has underscored the need for improved diagnostic methods...

   Reza Pishdad, Giorgio Treglia, ... Prasanna Santhanam in Endocrine

   Article 18 March 2024
   

2. Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers

   Purpose of Review

   The purpose of this paper is to provide a focused update on recent advances in non-18F-FDG radiotracers for myocardial inflammatory...

   Tiantian Shi, Edward J. Miller in Current Cardiovascular Imaging Reports

   Article 01 January 2023
   

3. PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies

   Abstract

   Prostatic neuroendocrine malignancies represent a spectrum of diseases. Treatment-induced neuroendocrine differentiation (tiNED) in...

   Dan Cohen, Shir Hazut Krauthammer, ... Einat Even-Sapir in European Radiology

   Article 13 April 2023
   

4. Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications

   Background

   Expanding therapeutic possibilities have improved disease-related prospects for breast cancer patients. Pathological analysis on a tumor...

   Renske Altena, Antonios Tzortzakakis, ... Rimma Axelsson in EJNMMI Research

   Article Open access 17 May 2023
   

5. AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT

   Background

   Segmenting the whole-body somatostatin receptor-expressing tumour volume (SRETVwb) on positron emission tomography/computed tomography...

   Anni Gålne, Olof Enqvist, ... Elin Trägårdh in European Journal of Hybrid Imaging

   Article Open access 07 August 2023
   

6. New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms

   Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumours derived from cells of neuroendocrine origin and can potentially arise everywhere...

   Emilia Fortunati, Giulia Argalia, ... Valentina Ambrosini in Current Treatment Options in Oncology

   Article Open access 24 March 2022

7. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

   Purpose

   To provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin...

   Nathalie L. Albert, Matthias Preusser, ... Norbert Galldiks in European Journal of Nuclear Medicine and Molecular Imaging

   Article Open access 20 June 2024

8. PET receptor imaging in breast cancer

   Most of the breast cancers overexpress certain receptors which have a role in development and progression of the disease. Receptors are also target...

   Ismet Sarikaya in Clinical and Translational Imaging

   Article 05 October 2023
   

9. PET/CT and PET/MRI in neuroendocrine neoplasms

   Advanced molecular imaging has come to play an integral role in the management of gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs)....

   Naveen Rajamohan, Hala Khasawneh, ... Ajit H. Goenka in Abdominal Radiology

   Article 15 April 2022
   

10. Reference myocardial uptake values on somatostatin receptor-targeted PET: not yet in preference to visual assessment

    Hwan Lee, Paco E. Bravo in Journal of Nuclear Cardiology

    Article 23 February 2023
    

11. Molecular imaging for evaluation of synovitis associated with osteoarthritis: a narrative review

    Recent evidence highlights the role of low-grade synovial inflammation in the progression of osteoarthritis (OA). Inflamed synovium of OA joints...

    Kwanghoon Lee, Soheil Niku, ... Monica Guma in Arthritis Research & Therapy

    Article Open access 16 January 2024
    

12. Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)

    Background

    In the US, EU and elsewhere, basic clinical research studies with positron emission tomography (PET) radiotracers that are generally...

    Isaac M. Jackson, So Jeong Lee, ... Peter J. H. Scott in EJNMMI Radiopharmacy and Chemistry

    Article Open access 11 November 2020
    

13. FDG PET/CT versus somatostatin receptor PET/CT in TENIS syndrome: a systematic review and meta-analysis

    Purpose

    In patients with TENIS syndrome (Thyroglobulin-Elevated Negative Iodine Scintigraphy), PET/CT radiotracers, such FDG PET/CT and somatostatin...

    Felipe Alves Mourato, Maria Amorim Almeida, ... Elba Etchebehere in Clinical and Translational Imaging

    Article 24 September 2020
    

14. Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation

    Background

    There is a need to develop methods for post-myocardial infarction (MI) inflammation monitoring. Scintigraphy with somatostatin receptor...

    Svetlana I. Sazonova, Julia N. Ilyushenkova, ... Vyacheslav V. Ryabov in Journal of Nuclear Cardiology

    Article 14 June 2023
    

15. A new ⁶⁸Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting

    Background

    Somatostatin receptor (SST) targeting, specifically of the subtype 2 (SST2), with radiolabeled somatostatin analogs, is established for...

    Rosalba Mansi, Karim Abid, ... Melpomeni Fani in EJNMMI Research

    Article Open access 05 August 2020
    

16. Radionuclide-based theranostics — a promising strategy for lung cancer

    Purpose

    This review aims to provide a comprehensive overview of the latest literature on personalized lung cancer management using different ligands...

    Tianxing Zhu, Jessica C. Hsu, ... Kai Wang in European Journal of Nuclear Medicine and Molecular Imaging

    Article 16 March 2023
    

17. Personalized Cardiac Imaging with New PET Radiotracers

    Purpose of Review

    This article reviews recent developments in the application of positron emission tomography (PET) for personalized cardiac imaging.

    ...

    Claudine Régis, Patrick Martineau, ... Matthieu Pelletier-Galarneau in Current Cardiovascular Imaging Reports

    Article 19 February 2020
    

18. Surgical radioguidance with beta-emitting radionuclides; challenges and possibilities: A position paper by the EANM

    Radioguidance that makes use of β-emitting radionuclides is gaining in popularity and could have potential to strengthen the range of existing...

    Pedro Fragoso Costa, Kuangyu Shi, ... Fijs W. B. van Leeuwen in European Journal of Nuclear Medicine and Molecular Imaging

    Article Open access 08 January 2024
    

19. Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities

    Due to its rarity and non-specific clinical presentation, accurate diagnosis, and optimal therapeutic strategy of medullary thyroid carcinoma (MTC)...

    Alessio Imperiale, Valentina Berti, ... Giorgio Treglia in Reviews in Endocrine and Metabolic Disorders

    Article 16 September 2023
    

20. PET/MRI imaging in neuroendocrine neoplasm

    Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for...

    Mayur K. Virarkar, Matthew Montanarella, ... Priya Bhosale in Abdominal Radiology

    Article 16 December 2022